Sera Prognostics (SERA) Change in Accured Expenses (2020 - 2026)
Sera Prognostics (SERA) posted Change in Accured Expenses of -$116000.0 for Q1 2026, down 115.41% on a QoQ basis from $753000.0 in Q4 2025, and up 76.42% year-over-year from -$65751.2 in Q1 2025.
Sera Prognostics (SERA) Change in Accured Expenses (2020 - 2026) Analysis & Trends
Sera Prognostics' Change in Accured Expenses history runs 7 years deep, the most recent figure standing at -$116000.0 for Q1 2026.
- Quarterly Change in Accured Expenses rose 76.42% year-over-year to -$116000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (up 200.47% YoY) and the FY2025 annual result came in at $682000.0, up 218.61% from the prior year.
- Change in Accured Expenses was -$116000.0 for Q1 2026 at Sera Prognostics, down from $753000.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $982000.0 in Q3 2022 and bottomed at -$1.9 million in Q1 2022.
- A 5-year average of -$166117.6 and a median of -$14000.0 in 2024 frame the typical range for Change in Accured Expenses.
- Peak annual rise in Change in Accured Expenses reached 1520.75% in 2025, while the deepest fall reached 3414.29% in 2025.
- Sera Prognostics' Change in Accured Expenses stood at $20000.0 in 2022, then tumbled by 1690.0% to -$318000.0 in 2023, then jumped by 83.33% to -$53000.0 in 2024, then soared by 1520.75% to $753000.0 in 2025, then plunged by 115.41% to -$116000.0 in 2026.
- Business Quant data shows SERA's Change in Accured Expenses at -$116000.0 in Q1 2026, $753000.0 in Q4 2025, and $16000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 145.10 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -250.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 21.07 Mn |
| 10 | Sera Prognostics | 105.54 Mn | 105.54 Mn | -28,000.00 | -116,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -116,000.00 |
| Mar 31, 2026 | -116,000.00 |
| Dec 31, 2025 | 753,000.00 |
| Dec 31, 2025 | 753,000.00 |
| Sep 30, 2025 | 16,000.00 |
| Sep 30, 2025 | 16,000.00 |
| Jun 30, 2025 | 405,000.00 |
| Jun 30, 2025 | 405,000.00 |
| Mar 31, 2025 | -492,000.00 |
| Mar 31, 2025 | -492,000.00 |
| Dec 31, 2024 | -53,000.00 |
| Dec 31, 2024 | -53,000.00 |
| Sep 30, 2024 | -666,000.00 |
| Sep 30, 2024 | -666,000.00 |
| Jun 30, 2024 | 158,000.00 |
| Jun 30, 2024 | 158,000.00 |
| Mar 31, 2024 | -14,000.00 |
| Mar 31, 2024 | -14,000.00 |
| Dec 31, 2023 | -318,000.00 |
| Dec 31, 2023 | -318,000.00 |